Global Joint Replacement Market Overview:
Joint replacement is when the arthritic or damaged bone is removed and replaced with an artificial joint to restore mobility and relieve pain. The most commonly performed joint replacement is for the hip and knee. Joint replacement is the ultimate treatment for advanced, symptomatic joint destruction regardless of the underlying cause. Modern joint replacement surgery includes removal of the worn cartilage from both sides of the joint, and rematerializing of the joint with a metal and plastic replacement implantation that looks and functions much like the normal joint.
Growth Drivers
- Increasing Aging Population
- Increasing Demand from the Cementless Joint Replacement Surgeries
Roadblocks
- High Cost of Implant
- Lack of Infrastructure Capacity to Perform Surgery Limits Its Penetration and Adoption
Opportunities
- Increasing Demand for the Customized Knee Implants
- Growing Healthcare Infrastructure in the Developing Countries
Challenges
- Availability of Other Orthopedic Care Services
Competitive Landscape:
Some of the key players profiled in the report are B. Braun Melsungen AG (Germany), Stryker Corporation (United States), AK Medical Holdings Limited (China), Dragonbio (China), Corin Group (United Kingdom), Mathys Ltd Bettlach (Switzerland), Smith & Nephew Plc (United Kingdom), Waldemar LINK GmbH & Co. KG (Germany), Medacta International (Switzerland), Exactech, Inc. (United States), DePuy Synthesand (United States), Zimmer Biomet (United States) and Johnson & Johnson Services, Inc. (United States). Analyst at AMA Research see European Players to retain maximum share of Global Joint Replacement market by 2026. Considering Market by Area of Treatment, the sub-segment i.e. Hip will boost the Joint Replacement market. Considering Market by Replacement Type , the sub-segment i.e. Total Replacement will boost the Joint Replacement market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Joint Replacement market.
In January 2013, the FDA published a proposed order to allow for notice and comment regarding the FDA's recommendation to change the requirements for all metal-on-metal (MoM) total hip implants from premarket notification, to premarket approval, the most stringent regulatory category of the FDA's oversight for medical devices. A final order was published in February 2016 and the requirement for filing premarket approvals was effective in May 2016. Since that time, all manufacturers of MoM total hip implants are required to stop marketing their devices and submit premarket approvals that must be approved before the devices can be marketed.
What Can be Explored with the Joint Replacement Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Joint Replacement Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Joint Replacement
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Joint Replacement market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Joint Replacement market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Small Joint Replacement Service Providers, Joint Replacement Equipment Manufactures, Suppliers of Medical Equipment, Healthcare Industry, Governmental Bodies and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.